DCT Patient Pathways
Increase site-mix performance
FutureMeds @home takes care of bottlenecks, patient burden & operational challenges to help you realise higher recruitment, retention rates and patient experience
Improved patient experience
Decentralised/hybrid models increase diverse populations' access to trials, boost patient-centric delivery,leading to higher engagement​ and data quality
Increased recruitment
& retention
By offering flexible participation from home, reducing burden, and improving patient convenience, decentralised trials improve attitudes toward participation.
Enhanced
data quality
& integrity
Decentralised/hybrid models reduce site bias, enable real-time monitoring, and ensure diverse, reliable patient data, leading to robust data integrity.
Key benefits of using DCT elements in your clinical trials
Enhancing the experience for your patients to boost retention
Scalable & flexible Solution
Gain greater reach & performance by boosting site performance and patient experience with one of FutureMeds @home patient pathways without losing PI oversight or data integrity
Intergrated
FutureMeds Sites +
FutureMeds @home
Hybrid approach with all 24 sites to increase patient access and improve retention
One virtual FutureMeds PI + remote SI network
Increase FutureMeds’ site reach with DCT expertise in TA & Patient Insight + Input for protocol designs ​
.png)
Stand Alone
Non-FutureMeds Sites + FutureMeds @home
Prolonged arm of Non-FutureMeds Sites & PIs to support hybrid approach across 18 European countries
Increase Site & PI engagement for DCT adoption
Increase the patient outreach & engagement of Non-FutureMeds Sites with HomeCare visits ​
Track record of delivering quality and improving patient experience
FutureMeds @home is the only European independent DCT solution with over 12 years of experience that combines deep site business expertise, capabilities, quality & resource management to create winning business outcomes for performance-conscious clients
320+
DCT trials
delivered
140+
indications
supported
12.5k+
home visits
delivered
120+
Sponsors
supported
40+
CROs
supported
1,850+
non-FutureMeds
sites supported
.png)